Acute uncomplicated lower urinary tract infections in general practice: Clinical and microbiological cute rates after three- versus five-day treatment with trimethoprim

European Journal of General Practice

Volumn 11, Issue 2, 2005, Pages 55-58

  van Merode, Tiny ^a   Nys, Sita ^a   Raets, Inge ^a   Stobberingh, Ellen E ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Duration of therapy; Trimethoprim and cure rate; UTI

Indexed keywords

TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENERAL PRACTITIONER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PERSISTENT INFECTION; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SHORT COURSE THERAPY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; URINALYSIS; URINARY TRACT INFECTION;

EID: 27544456831     PISSN: 13814788     EISSN: None     Source Type: Journal    
DOI: 10.3109/13814780509178238     Document Type: Article

References (11)

1. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000;10(8):509-15.
2. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002;113(Suppl 1A):S14-9.
3. Richard GA, Mathew CP, Kirstein JM, Orchard D, Yang JY. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Urology 2002;59(3):334-9.
4. Henry DC, Nenad RC, Iravani A, Tice AD, Mansfield DL, Magner DJ, et al. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group. Clin Ther 1999;21(6):966-81.
5. Trienekens TA, London NH, Houben AW, De Jong RA, Stobberingh EE. Treating acute urinary tract infections. An RCT of 3-day versus 7-day norfloxacin. Can Fam Physician 1993;39:514-8.
6. Gossius G, Vorland L. A randomised comparison of single-dose vs. three-day and ten-day therapy with trimethoprim-sulfamethoxazole for acute cystitis in women. Scand J Infect Dis 1984;16(4):373-9.
7. Lutters M, Vogt N. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev 2002(3):CD001535.
8. Trienekens TA, Stobberingh EE, Winkens RA, Houber AW. Different lengths of treatment with co-trimoxazole for acute uncomplicated urinary tract infections in women. Br Med J 1989;299:1319-22.
9. Lawrenson RA, Logie JW. Antibiotic failure in the treatment of urinary tract infections in young women. J Antimicrob Chemother 2001;48(6):895-901.
10. SWAB. NethMap 2004 Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands.
11. Christiaens TC, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 2002;52(482):729-34.